PortfoliosLab logoPortfoliosLab logo
ISIN
CA23126M1023

Highlights

Market Cap
$2.66B
Enterprise Value
$2.55B
EPS (TTM)
-$0.13
Total Revenue (TTM)
$1.30B
Gross Profit (TTM)
$528.91M
EBITDA (TTM)
$188.46M
Year Range
$3.64 - $10.92
Target Price
$13.02
ROA (TTM)
-3.65%
ROE (TTM)
-12.50%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

CURLF Performance Chart


Loading charts...

S&P 500 Index

Returns By Period


Curaleaf Holdings, Inc.

1D
6.34%
1M
176.37%
6M
YTD
1Y
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
-0.79%
1M
1.13%
6M
7.71%
YTD
9.79%
1Y
20.06%
3Y*
18.60%
5Y*
11.43%
10Y*
13.27%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CURLF Monthly Returns History

Based on dividend-adjusted daily data since Jun 5, 2026, CURLF's average daily return is +14.34%, while the average monthly return is +54.85%. At this rate, an investment would double in approximately 0.1 years.

Historically, 50% of months were positive and 50% were negative. The best month was Jul 2026 with a return of +176.4%, while the worst month was Jun 2026 at -66.7%. The longest winning streak lasted 1 consecutive months, and the longest losing streak was 1 months.

On a daily basis, CURLF closed higher 57% of trading days. The best single day was Jul 6, 2026 with a return of +161.0%, while the worst single day was Jun 5, 2026 at -66.7%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-66.67%176.37%-7.88%

Return for Risk

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Curaleaf Holdings, Inc. (CURLF) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CURLFBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.29

Calmar ratioReturn relative to maximum drawdown

2.21

Martin ratioReturn relative to average drawdown

9.61

Dividends

Dividend History


Curaleaf Holdings, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Curaleaf Holdings, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Curaleaf Holdings, Inc. was 66.67%, occurring on Jun 5, 2026. The portfolio has not yet recovered.

The current Curaleaf Holdings, Inc. drawdown is 7.88%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-66.67%Jun 2026
0s
1mo 9dJun 2026 - now

Drawdown Indicators


CURLFBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-66.67%

-56.78%

-9.89%

Max Drawdown (1Y)

Largest decline over 1 year

-9.10%

Max Drawdown (3Y)

Largest decline over 3 years

-18.90%

Max Drawdown (5Y)

Largest decline over 5 years

-25.43%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-7.88%

-1.24%

-6.64%

Average Drawdown

Average peak-to-trough decline

-20.12%

-10.71%

-9.41%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.09%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Curaleaf Holdings, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Curaleaf Holdings, Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CURLF relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, CURLF has a P/S ratio of 6.0. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for CURLF in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, CURLF has a P/B value of 9.5. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with CURLF

Add Curaleaf Holdings, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with CURLF